Translational Development Acquisition Corp Warrants
TDACW
28 hedge funds and large institutions have $10.4M invested in Translational Development Acquisition Corp Warrants in 2026 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 10 closing their positions.
932% more capital invested
Capital invested by funds: $1.01M → $10.4M (+$9.42M)
3.5% less ownership
Funds ownership: 89.37% → 85.87% (-3.5%)
13% less funds holding
Funds holding: 32 → 28 (-4)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
63% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LA
Linden Advisors
New York
|
+$1.02M |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
+$356K |
| 3 |
Calamos Advisors
Naperville,
Illinois
|
+$186K |
| 4 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$176K |
| 5 |
D.E. Shaw & Co
New York
|
+$176K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CL
CSS LLC
Chicago,
Illinois
|
-$404K |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$275K |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
-$257K |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$96.4K |
| 5 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$95.8K |
TDACW Hedge Fund Activity: Q2 2026 in Review
28 of the 8,326 institutional investors tracked by Wall St. Rank reported a position in Translational Development Acquisition Corp Warrants (TDACW) for Q2 2026, worth a combined $10.4M — up 932% from $1.01M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of TDACW and 6 opened new positions — a net loss of 4 holders — while 8 trimmed existing stakes and 3 added.
The largest buyer was Linden Advisors, adding an estimated $1.02M. The largest seller was CSS LLC, cutting an estimated $404K.
- 28 institutional investors held Translational Development Acquisition Corp Warrants (TDACW) as of Q2 2026, down from 32 in Q1 2026.
- Funds reported $10.4M of Translational Development Acquisition Corp Warrants stock for Q2 2026, up 932% quarter-over-quarter.
- 6 funds opened new Translational Development Acquisition Corp Warrants positions in Q2 2026 and 10 closed out, a net change of -4 holders.
- The largest Translational Development Acquisition Corp Warrants buyer in Q2 2026 was Linden Advisors, an estimated $1.02M added.
- The largest Translational Development Acquisition Corp Warrants seller in Q2 2026 was CSS LLC, an estimated $404K sold.
Based on aggregated 13F filings for Q2 2026.